Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 1, 2023 | Bowang Pharmaceutical | $41.0M Series A | — | Zhang Yi |
| Apr 25, 2023 | Adcentrx Therapeutics | $38.0M Series A | Tao Huang | Jeffrey Jonas, Delta Capital, F-Prime Capital |
| Aug 8, 2022 | Epigenic Therapeutics | $20.0M Pre-Series A | — | FountainBridge Capital, Kingray Capital, Michael Xue |
| Jun 14, 2021 | HiFiBiO | $75.0M Series D | Ryan Jeong | B Capital Group, Grand Mount, Hong Kong Science and Technology Parks Corporation, IDG Capital, Maison Capital, Sequoia Capital, Sherpa |